P14780 (MMP9_HUMAN) Homo sapiens (Human)
Matrix metalloproteinase-9 UniProtKBInterProSTRINGInteractive Modelling
707 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
29 Experimental Structures
Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
---|---|---|---|---|---|---|
Structure determination of a potent, selective antibody inhibitor of human MMP9 (GS-5745 bound to M… |
Heteromer | 100.0 | 2×ZN; 2×CA; 1×NCO; | |||
Crystal structure of mutant MMP-9 catalytic domain in complex with a twin inhibitor. | homo-2-mer | 100 | 4×ZN; 6×CA; 1×L29; | |||
Crystal structure of an MMP twin carboxylate based inhibitor LC20 in complex with the MMP-9 catalyt… | homo-2-mer | 100 | 4×ZN; 6×CA; 1×0ZD; 5×GOL; 6×PGO; 7×PEG; 1×MLT; | |||
MMP9 active site mutant-inhibitor complex | homo-2-mer | 100 | 8×CA; 2×STN; 2×BUM; 4×ZN; | |||
Dimeric form of the haemopexin domain of MMP9 | homo-2-mer | 98.97 | 4×SO4; | |||
Crystal structure of human matrix metalloproteinase MMP9 (gelatinase B). | monomer | 99.75 | 2×ZN; 3×CA; | |||
Crystal structure of human proMMP-9 catalytic domain in complex with inhibitor | monomer | 100 | 2×ZN; 3×CA; 1×VP6; 1×2HP; | |||
Crystal structure of human proMMP-9 catalytic domain in complex with inhibitor | monomer | 100.0 | 2×ZN; 3×CA; 1×VOC; | |||
Crystal structure of human proMMP-9 catalytic domain in complex with inhibitor | monomer | 100.0 | 2×ZN; 3×CA; 1×VOO; | |||
Crystal structure of human proMMP-9 catalytic domain in complex with inhibitor | monomer | 100.0 | 2×ZN; 3×CA; 1×VOZ; | |||
proMMP-9desFnII complexed to JNJ0966 INHIBITOR | monomer | 100.0 | 2×ZN; 3×CA; 1×SO4; | |||
proMMP-9desFnII | monomer | 100 | 2×ZN; 3×CA; 2×SO4; | |||
Structure determination of a potent, selective antibody inhibitor of human MMP9 (apo MMP9) | monomer | 100.0 | 2×ZN; 3×CA; | |||
Crystal structure of an inactive mutant of MMP-9 catalytic domain in complex with a fluorogenic syn… | monomer | 100 | 1×AZI; 2×ZN; 1×CA; 2×SR; 1×PGO; 2×EDO; 1×PEG; 1×GOL; | |||
Crystal structure of an MMP broad spectrum hydroxamate based inhibitor CC27 in complex with the MMP… | monomer | 100 | 2×ZN; 3×CA; 1×10B; 6×GOL; 1×PGO; | |||
Crystal structure MMP-9 complexes with a constrained hydroxamate based inhibitor LT4 | monomer | 100 | 2×ZN; 3×CA; 1×LTQ; 2×EDO; 1×PGO; | |||
Crystal structure of an inactive mutant of MMP-9 catalytic domain in complex with a fluorogenic syn… | monomer | 100 | 1×AZI; 2×ZN; 2×CA; 1×SR; 5×EDO; 1×GOL; 1×PGO; | |||
Crystal structure of an MMP twin inhibitor complexing two MMP-9 catalytic domains | monomer | 100 | 2×ZN; 2×CA; 6×PEG; 3×ACT; 2×BCN; | |||
Crystal structure of mutant MMP-9 catalytic domain in complex with a twin inhibitor. | monomer | 100 | 2×ZN; 4×CA; 1×0XX; | |||
MMP-9 active site mutant with barbiturate inhibitor | monomer | 100 | 2×ZN; 5×CA; 3×CL; 1×4MR; | |||
MMP-9 active site mutant with phosphinate inhibitor | monomer | 100 | 2×ZN; 5×CA; 3×CL; 1×5MR; | |||
MMP-9 active site mutant with iodine-labeled carboxylate inhibitor | monomer | 100 | 2×ZN; 4×CA; 4×CL; 1×6MR; | |||
MMP-9 active site mutant with trifluoromethyl hydroxamate inhibitor | monomer | 100 | 2×ZN; 4×CA; 3×CL; 1×7MR; | |||
MMP9-inhibitor complex | monomer | 100 | 5×CA; 1×NFH; 2×ZN; | |||
Crystal structure of MMP9 in complex with inhibitor BE4. | monomer | 100 | 2×ZN; 3×CA; 1×B9Z; 1×PZE; | |||
Crystal structure of a hydroxamate based inhibitor EN140 in complex with the MMP-9 catalytic domain | monomer | 100 | 1×E40; 2×ZN; 3×CA; 1×EDO; 2×PGO; 2×PEG; | |||
Crystal structure of a hydroxamate based inhibitor ARP101 (EN73) in complex with the MMP-9 catalyti… | monomer | 100 | 1×N73; 2×ZN; 3×CA; 2×DMS; 4×EDO; 1×GOL; 2×PGO; 1×BUD; | |||
Crystal structure of the catalytic domain of MMP-9 in complex with a selective sugar-conjugated ary… | monomer | 100 | 2×ZN; 3×CA; 1×H27; 1×EDO; 1×DMS; 1×GOL; | |||
MMP-9 active site mutant with difluoro butanoic acid inhibitor | monomer | 100 | 2×ZN; 3×CA; 2×CL; 1×8MR; | |||
2 SWISS-MODEL models
Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
1ck7.1.A | monomer | 0.69 | 1×ZN; 1×CA; | 48.47 | ||
1gxd.1.A | monomer | 0.53 | 28.53 | |||